Literature DB >> 2736832

Anti-La (SS-B): a diagnostic criterion for Sjögren's syndrome?

P J Venables1, W Shattles, C T Pease, J E Ellis, P J Charles, R N Maini.   

Abstract

We examined the diagnostic sensitivity and specificity of antibodies to Ro (SS-A) and La (SS-B) in Sjögren's syndrome (SS) by counterimmunoelectrophoresis and immunodiffusion. Anti-Ro was found in 56% and anti-La in 42% of patients with SS and in 38% and 6% respectively in SLE. Anti-La was rare (less than 1%) in other connective tissue diseases. As a more stringent test of diagnostic specificity, 88 patients whose sera contained anti-La and/or anti-Ro were carefully examined for evidence of Sjögren's syndrome. Of 35 patients whose sera contained anti-La, 29 (83%) fulfilled criteria for SS, and four out of 6 of the remainder showed some evidence of early disease. Of 53 patients with anti-Ro (without anti-La), only 42% had Sjögren's syndrome, 45% had SLE and 13% other connective tissue diseases. These data confirm that anti-La, but not anti-Ro, has a high diagnostic specificity for Sjögren's syndrome and merits inclusion as separate diagnostic criterion for the disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2736832

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  8 in total

1.  Clinical differences between ANA/anti-ENA positive or negative primary Sjögren's syndrome.

Authors:  V Fossaluzza; S De Vita
Journal:  Clin Rheumatol       Date:  1992-09       Impact factor: 2.980

Review 2.  Autoantibodies in Sjögren's Syndrome.

Authors:  Anum Fayyaz; Biji T Kurien; R Hal Scofield
Journal:  Rheum Dis Clin North Am       Date:  2016-06-21       Impact factor: 2.670

Review 3.  Sjögren syndrome.

Authors:  Clio P Mavragani; Haralampos M Moutsopoulos
Journal:  CMAJ       Date:  2014-02-24       Impact factor: 8.262

4.  Weak association between subjective symptoms or and objective testing for dry eyes and dry mouth: results from a population based study.

Authors:  E M Hay; E Thomas; B Pal; A Hajeer; H Chambers; A J Silman
Journal:  Ann Rheum Dis       Date:  1998-01       Impact factor: 19.103

5.  Prognostic value of Sjögren's syndrome autoantibodies.

Authors:  R Hal Scofield; Anum Fayyaz; Biji T Kurien; Kristi A Koelsch
Journal:  J Lab Precis Med       Date:  2018-10-30

6.  Detection of a rare oligo(A) repeat tract mutation (8As-->7As) in the sequence encoding the La/SS-B autoantigen.

Authors:  Imre Semsei; Shannon Maier; Jennifer Workman-Azbill; László Urbán; Kathy Moser; Margit Zeher; Michael Bachmann; A Darise Farris
Journal:  Anal Biochem       Date:  2007-07-05       Impact factor: 3.365

7.  Anti-alpha-fodrin antibodies do not add much to the diagnosis of Sjögren's syndrome.

Authors:  Michiel M Zandbelt; Judith Vogelzangs; Leo BA Van De Putte; Walther J Van Venrooij; Frank HJ Van Den Hoogen
Journal:  Arthritis Res Ther       Date:  2003-10-31       Impact factor: 5.156

8.  Isolated positive anti-SS-B autoantibodies are not related to clinical features of systemic autoimmune diseases: Results from a routine population survey.

Authors:  Sabine Jardel; Nicole Fabien; Arnaud Hot; Sandra Vukusic; Jacques Tebib; Vincent Cottin; Pascal Sève; Maurice Laville; Alexandre Belot; Isabelle Durieu; Lorna Garnier; Frédéric Coutant; Quitterie Reynaud; Jean Christophe Lega
Journal:  PLoS One       Date:  2017-09-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.